The FDA is considering whether to regulate mobile applications, including smartphone apps, that enable patients to wirelessly monitor their vital signs, such as heart rhythm monitors and glucose monitoring systems. "Developing and integrating wireless and broadband communications technology with medical devices and applications requires agencies to assure that such devices operate in a safe, reliable and secure manner," said officials from the FDA and the Federal Communications Commission.

Full Story:

Related Summaries